AAV-CD74 gene therapy (University of Nebraska Medical Center)

N/A

Report date: 2025/01/26 18:11:38

Base Information

Drug NameAAV-CD74 gene therapy (University of Nebraska Medical Center)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionHLA-DR antigens-associated invariant chain modulators
TargetsHLA-DR antigens-associated invariant chain
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Nebraska Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesUNeMed CorpUniversity Of Nebraska Medical Center
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A